FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

10637511000001101: Apo-Hydralazine 10mg tablets (Apotex Inc) 100 tablet (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 02-Oct 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
36269201000001112 Apo-Hydralazine 10mg tablets (Apotex Inc) 100 tablet (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
43181801000001119 Apo-Hydralazine 10mg tablets (Imported (United States)) 100 tablet en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Apo-Hydralazine 10mg tablets (Apotex Inc) 100 tablet Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Apo-Hydralazine 10mg tablets (Apotex Inc) 100 tablet Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction imported true Inferred relationship Existential restriction modifier
Apo-Hydralazine 10mg tablets (Apotex Inc) 100 tablet Is a Hydralazine 10mg tablets 100 tablet true Inferred relationship Existential restriction modifier
Apo-Hydralazine 10mg tablets (Apotex Inc) 100 tablet Is pack of Apo-Hydralazine 10mg tablets (Apotex Inc) false Inferred relationship Existential restriction modifier
Apo-Hydralazine 10mg tablets (Apotex Inc) 100 tablet Has active ingredient Hydralazine hydrochloride false Inferred relationship Existential restriction modifier
Apo-Hydralazine 10mg tablets (Apotex Inc) 100 tablet Has manufactured dose form Tablet false Inferred relationship Existential restriction modifier
Apo-Hydralazine 10mg tablets (Apotex Inc) 100 tablet Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Apo-Hydralazine 10mg tablets (Apotex Inc) 100 tablet Discontinued indicator Never discontinued true Inferred relationship Existential restriction modifier
Apo-Hydralazine 10mg tablets (Apotex Inc) 100 tablet Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Apo-Hydralazine 10mg tablets (Apotex Inc) 100 tablet VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Apo-Hydralazine 10mg tablets (Apotex Inc) 100 tablet VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Apo-Hydralazine 10mg tablets (Apotex Inc) 100 tablet Has AMP Apo-Hydralazine 10mg tablets (Apotex Inc) true Inferred relationship Existential restriction modifier
Apo-Hydralazine 10mg tablets (Apotex Inc) 100 tablet Has specific active ingredient Hydralazine hydrochloride true Inferred relationship Existential restriction modifier
Apo-Hydralazine 10mg tablets (Apotex Inc) 100 tablet Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Apo-Hydralazine 10mg tablets (Apotex Inc) 100 tablet Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start